Purdue Pharma Executives Wanted to Get into Anti-Addiction Market
Lawsuit claims Purdue Pharma and the Sackler family had planned to get into the anti-addiction market. The company boosted sales of OxyContin while discussing these plans so its executives could profit on both ends.








